BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24464500)

  • 21. A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues.
    Baricevic I; Jones DR; Roberts DL; Lutzen A; Lundby A; Worm J; Hansen BF; Renehan AG
    Carcinogenesis; 2015 Sep; 36(9):1040-50. PubMed ID: 26026165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
    Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P
    Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitogenic potency of insulin glargine.
    Zełobowska K; Gumprecht J; Grzeszczak W
    Endokrynol Pol; 2009; 60(1):34-9. PubMed ID: 19224503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogue.
    Werner U; Korn M; Schmidt R; Wendrich TM; Tennagels N
    Arch Physiol Biochem; 2014 Oct; 120(4):158-65. PubMed ID: 25144413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of INSR/IGF1R by C-myc promotes TSCC tumorigenesis and metastasis through the NF-κB pathway.
    Sun J; Lu Z; Deng Y; Wang W; He Q; Yan W; Wang A
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1873-1882. PubMed ID: 29518496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors.
    Bronsveld HK; De Bruin ML; Wesseling J; Sanders J; Hofland I; Jensen V; Bazelier MT; Ter Braak B; de Boer A; Vestergaard P; Schmidt MK
    BMC Cancer; 2018 Feb; 18(1):224. PubMed ID: 29486734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production.
    Ter Braak B; Siezen CL; Lee JS; Rao P; Voorhoeve C; Ruppin E; van der Laan JW; van de Water B
    Breast Cancer Res; 2017 Feb; 19(1):14. PubMed ID: 28173837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.
    Erdem C; Lee AV; Taylor DL; Lezon TR
    PLoS Comput Biol; 2021 Jun; 17(6):e1009125. PubMed ID: 34191793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.
    Heidegger I; Kern J; Ofer P; Klocker H; Massoner P
    Oncotarget; 2014 May; 5(9):2723-35. PubMed ID: 24809298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation.
    Scalia P; Williams SJ; Fujita-Yamaguchi Y; Giordano A
    Cell Cycle; 2023 Jan; 22(1):1-37. PubMed ID: 36005738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 1 Insulin-Like Growth Factor Receptor/Insulin Receptor Substrate 1 Signaling Confers Pathogenic Activity on Breast Tumor Cells Lacking REST.
    Meyer K; Albaugh B; Schoenike B; Roopra A
    Mol Cell Biol; 2015 Sep; 35(17):2991-3004. PubMed ID: 26100015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
    Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
    Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells.
    Weinstein D; Simon M; Yehezkel E; Laron Z; Werner H
    Diabetes Metab Res Rev; 2009 Jan; 25(1):41-9. PubMed ID: 19145584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin and its analogues and their affinities for the IGF1 receptor.
    Varewijck AJ; Janssen JA
    Endocr Relat Cancer; 2012 Oct; 19(5):F63-75. PubMed ID: 22420005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation.
    Tognon CE; Rafn B; Cetinbas NM; Kamura T; Trigo G; Rotblat B; Okumura F; Matsumoto M; Chow C; Davare M; Pollak M; Mayor T; Sorensen PH
    J Biol Chem; 2018 Aug; 293(32):12502-12515. PubMed ID: 29903916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups.
    Björner S; Rosendahl AH; Simonsson M; Markkula A; Jirström K; Borgquist S; Rose C; Ingvar C; Jernström H
    Oncotarget; 2017 Feb; 8(6):9093-9107. PubMed ID: 28030849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells.
    Xuan S; Szabolcs M; Cinti F; Perincheri S; Accili D; Efstratiadis A
    J Biol Chem; 2010 Dec; 285(52):41044-50. PubMed ID: 20947509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues.
    Lundby A; Bolvig P; Hegelund AC; Hansen BF; Worm J; Lützen A; Billestrup N; Bonnesen C; Oleksiewicz MB
    J Appl Toxicol; 2015 Jul; 35(7):842-50. PubMed ID: 25413577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.